About me
Jesús Martín García is CEO of Peptomyc, with over two decades of leadership in drug development, biotech strategy and corporate finance. He has held CEO and Board roles, leading clinical-stage programs, partnering transactions and capital raises from Series A through IPO. He holds an MBA from Harvard Business School and degrees in Law and Economics from the University of Geneva.
